Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome

This study has been completed.
Sponsor:
Collaborators:
Novo Nordisk A/S
The County of Frederiksborg
The foundation of Kaptajnløjtnant Harald Jensen and Wife
The foundation of Mrs. Olga Bryde
The foundation of Mr. Ivan Nielsen
Information provided by (Responsible Party):
Line Cleemann, Hillerod Hospital, Denmark
ClinicalTrials.gov Identifier:
NCT00134745
First received: August 24, 2005
Last updated: June 13, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)